We are a molecular diagnostics company developing and commercializing a pipeline of proprietary products for the screening and diagnosis of cancer.
Our products enable doctors to diagnose cancer earlier and more accurately, leading to improved outcomes for patients.
Our lead product, Epi proColon®, is a blood-based test for the early detection of colorectal cancer, which is currently marketed in Europe and is in development for the U.S.A..
Our technology and products have been validated through multiple partnerships with leading global diagnostic companies and testing laboratories.
We are an international company with operations in Europe and the U.S.A.
Location: United States, California, San Diego
Employees: 51-200
Phone: +1 858-429-6199
Founded date: 1998
Investors 3
Mentions in press and media 14
| Date | Title | Description | Source |
| 07.03.2024 | Europe Colorectal Cancer Screening and Diagnostic Market Ana... | - | globenewsw... |
| 14.03.2023 | Startup Showcase: Epigenomics – Early Cancer Detection throu... | Epigenomics is a Berlin-based startup that focuses on developing and manufacturing a pipeline of pro... | eustartup.... |
| 10.11.2021 | Epigenomics AG publishes financial results for the first nin... | DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results Epigenomics A... | marketscre... |
| 10.11.2021 | PRESS RELEASE : Epigenomics AG publishes financial results f... | DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement/Quarter Results Epigenomics A... | marketscre... |
| 07.10.2021 | Epigenomics AG: EVP of Finance Albert Weber leaves the Compa... | DGAP-News: Epigenomics AG / Key word(s): Personnel Epigenomics AG: EVP of Finance Albert Weber leave... | marketscre... |
| 02.09.2021 | Epigenomics : ???????New study in the BMC Cancer journal sho... | DGAP-News: Epigenomics AG / Key word(s): Study results/Study ???????New study in the BMC Cancer jour... | marketscre... |
| 24.08.2021 | PRESS RELEASE : Epigenomics AG: Securities prospectus for th... | DGAP-News: Epigenomics AG / Key word(s): Issue of Debt/Corporate Action Epigenomics AG: Securities p... | marketscre... |
| 17.08.2021 | DGAP-Adhoc : Epigenomics AG: Execution of a Biobank Sale Agr... | DGAP-Ad-hoc: Epigenomics AG / Key word(s): Strategic Company Decision/Change in Forecast Epigenomics... | marketscre... |
| 30.07.2021 | Epigenomics AG: Preliminary announcement of the publication ... | DGAP Preliminary announcement financial reports: Epigenomics AG / Preliminary announcement on the di... | marketscre... |
| 11.05.2021 | EPIGENOMICS AG DGAP-AFR : Epigenomics AG: Preliminary annou... | DGAP Preliminary announcement financial reports: Epigenomics AG / Preliminary announcement on the di... | marketscre... |
Show more